Why Does Transfection Efficiency Drop Dramatically with Large Plasmids? Before Switching Reagents, Start by Checking the Number of DNA Molecules

Transfection with 4–5 kb plasmids may be consistently successful, but when you switch to a construct larger than 10 kb, the same transfection reagent, cell density, and incubation time may produce noticeably weaker fluorescence the next day, along with widespread cell death.

The first instinct is often to suspect poor plasmid purity. However, plasmid quality is only one part of the equation. Larger plasmids introduce additional constraints across multiple stages of the transfection process. Changing several variables at once makes it difficult to identify the actual bottleneck.

Start with DNA Copy Number, Then Check Plasmid Topology and Quality: Three Common Sources of Misinterpretation

At the same DNA mass, larger plasmids contain fewer DNA molecules. For example, 1 μg of a 5 kb plasmid contains approximately 2 × 10¹¹ molecules, while 1 μg of a 15 kb plasmid contains approximately 6 × 10¹⁰ molecules—only about one-third as many.

If you continue using the same DNA mass as you would for a smaller plasmid, the number of plasmid copies available for cellular delivery is already substantially lower. To match the molecular input, the total DNA mass needs to increase with plasmid size. The appropriate adjustment should be determined empirically for each transfection system.

DNA concentration readings also do not necessarily reflect the number of usable plasmid molecules. Spectrophotometric measurements detect total nucleic acid absorbance, which may include contributions from single-stranded DNA and residual RNA. When necessary, verify the concentration using a fluorescence-based assay. This is generally more reliable than repeatedly increasing the sample volume based on an unverified spectrophotometric reading.

Another easily overlooked issue is the use of seed-form plasmid DNA powder without first transforming and amplifying it. This format is not intended for direct transfection and may result in extremely low efficiency—a pattern that can easily be mistaken for a problem caused by plasmid size.

Miaoling offers three product formats: ready-to-use liquid plasmid DNA, seed-form plasmid DNA powder, and seed-form glycerol bacterial stocks. For direct transfection, the appropriate format is ready-to-use liquid plasmid DNA. Confirm which format you have before adjusting your transfection conditions.

Next, evaluate three key aspects of plasmid quality: the proportion of supercoiled DNA, endotoxin levels, and residual salts or ethanol.

Large plasmids may be more susceptible to nicking and fragmentation during preparation and storage. A reduced supercoiled fraction can affect DNA complex formation and resistance to nuclease degradation. Endotoxins can trigger inflammatory responses, while residual salts may interfere with electrostatic interactions and residual ethanol can compromise cell viability.

For transfection-grade plasmid DNA, supercoiled content and endotoxin levels are important quality-control parameters. Miaoling's specification for transfection-grade products requires endotoxin levels below 0.1 EU/μg.

Running an agarose gel to assess plasmid topology can provide more useful information than relying on concentration readings alone.

Complex Formation: Using the Same Reagent-to-DNA Ratio as for Small Plasmids Can Lead to Incomplete Complexation and Aggregation

Chemical transfection requires DNA to be condensed into nanoscale complexes before cellular delivery. PEI- or lipid-based reagents interact with the negatively charged phosphate backbone of DNA through electrostatic interactions. Larger plasmids contain more negatively charged sites, so a greater amount of transfection reagent may be needed to form uniformly condensed particles.

If you continue using a reagent-to-DNA ratio optimized for a smaller plasmid, there may be not enough reagent to fully complex the DNA. This can result in uneven surface charge distribution and increase the likelihood of particle aggregation.

Aggregation can have several consequences. When particle size increases to approximately 1 μm or larger, cellular uptake may decrease. Larger particles may also increase the burden on endocytic pathways and contribute to cellular stress.

This creates a difficult trade-off: insufficient DNA condensation can reduce transfection efficiency, while adding more reagent may leave excess free reagent in the system. The resulting positive charge can compromise cell membrane integrity, leading to widespread cell death.

This may explain why a sharp decline in fluorescence and extensive cell death often occur together: both can result from the same underlying problem.

Serum or antibiotics in the dilution medium may interfere with electrostatic interactions. Vigorous pipetting or vortexing can also disrupt and reorganize complexes that have already formed. A common approach is to prepare complexes in serum-free, antibiotic-free diluent, mix gently by inversion, and follow the reagent manufacturer's recommended incubation time.

The solution is not simply to increase the reagent dose. Instead, perform a dose-response optimization. After adjusting the total DNA input according to plasmid size, test several reagent amounts in parallel. Record both the percentage of fluorescent-positive cells and cell viability. Looking at fluorescence-positive rates alone can be misleading: a condition that causes extensive cell death may appear to improve transfection efficiency simply because the surviving cell population is not representative.

There is another easily overlooked factor when setting up these optimization experiments: the amount of DNA required.

Splitting an experiment into four groups can substantially increase total DNA consumption compared with

https://www.miaolingbio.net
Wuhan MiaoLing Biotechnology Co., Ltd.